Company / Capital Returned to Shareholders
PLUS THERAPEUTICS, INC. Capital Returned to Shareholders History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$374.0K
FY2025
5-year range
$126.0K / $374.0K
FY2024-FY2025
Trend
+196.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$374,000 in FY2025.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, capital returned to shareholders increased 196.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $374.0K | +196.8% |
| FY2024 | $126.0K | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
| FY2013 | - | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026